Ahmad, S., Zaman, M., Idrees, N., Gul, R., Aziz, Y. and Ahmad, F. 2026. Evaluation of the Efficacy of Rifaximin versus Mebeverine in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: Rifaximin versus Mebeverine in the Treatment of Diarrhea-Predominant IBS. Pakistan Journal of Health Sciences. 7, 3 (Mar. 2026), 124–130. DOI:https://doi.org/10.54393/pjhs.v7i3.3757.